Predictive Models

There are a number of models that allow doctors to assist patients in predicting the risk of prostate cancer recurrence following therapy. These nomograms (mathematical models) are used to predict the risk of PSA failure after treatment and may help to educate men and their families to the risk of suffering PSA failure after surgery or radiation therapy. PSA failure refers to a rising PSA after treatment.

It should be remembered that these models have accuracy rates somewhere in the 75% range. While these models are useful during discussions about treatments of prostate cancer, models should be placed into perspective by the patient and physician with regard to the individual patient’s overall health status and personal preferences for treatment.

Discussing cancer treatment options are perplexing. Patient’s anxieties can be relieved by understanding the high chances of overall success from either radiation therapy or surgical treatment options. Urologists and radiation treatment specialists have been early pioneers in the use of mathematical models for educating patients. Any questions that patients may have about the use of these models should be brought up during their discussion with their doctors.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.